Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Indonesian Journal of Cardiology JSFK (Jurnal Sains Farmasi & Klinis)
Evananda, Maria Pramesthi Sabrina
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Dendritic-Cell Specific Antigen Hiv-1: Novel Terapi Berbasis Biomolekuler sebagai Imunomodulator pada Penderita HIV Tipe 1 Salim, Albert; Evananda, Maria Pramesthi Sabrina; Prasetyo, Aizar Vesa; Trapika, I Gusti Made Gde Surya Chandra
JSFK (Jurnal Sains Farmasi & Klinis) Vol 8 No 3 (2021): J Sains Farm Klin 8(3), Desember 2021
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.8.3.258-263.2021

Abstract

Infeksi Human Immunodeficiency Virus (HIV), baik tipe 1 yang tersebar ke seluruh dunia maupun tipe 2 yang terisolasi di Afrika, masih menjadi tantangan di bidang kesehatan dunia termasuk Indonesia. Angka HIV yang tinggi ini penting untuk ditangani karena bahaya komplikasi yang mengintai. Penatalaksanaan dan terapi HIV yang ada saat ini dengan penggunaan antiretroviral memiliki keterbatasan dilihat dari efek terapi dan efek samping yang ditimbulkan. Pengembangan dan penemuan modalitas terapi yang memiliki potensi efek terapi yang lebih optimal merupakan suatu tantangan yang terus diupayakan dalam penanganan HIV ini. Salah satunya adalah pengembangan imunoterapi berbasis sel dendritik. Literature review ini ditulis secara sistematis mengenai laporan studi terkait hal di atas dari berbagai sumber termasuk Google Scholar, PubMed, Research Gate untuk menguraikan potensi sel dendritik sebagai imunomodulator pada penderita HIV-1. Modalitas imunoterapi ini dikonstruksi dalam bentuk vaksin berbasis sel dendritik, sel yang berperan pada patogenesis HIV, yang diadministrasikan secara intradermal. Vaksin yang diberikan akan menstimulasi respon imun dan dapat digunakan tidak saja sebagai upaya terapi pada penderita tapi berpotensi digunakan sebagai pencegahan.
Collagen-Based Hydrogel Encapsulated Cardiosphere-Derived Cell (CDC): Potential of Stem Cells as Tissue Repair Therapy Post-Acute Myocardial Infarction Evananda, Maria Pramesthi Sabrina; Salim, Albert; Surya, Stevanus Christian; Suastika, Luh Olivia Saraswati
Jurnal Kardiologi Indonesia Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1281

Abstract

Acute myocardial infarction (AMI) is a global health issue that is the leading cause of morbidity and mortality. Post-AMI management currently has therapeutic and side effect limitations, and has not been able to repair damage to myocardial tissue caused by AMI. The development and discovery of therapeutic modalities with the potential for a more optimal therapeutic effect remains a challenge in this post-AMI treatment. The purpose of this literature review is to collect and analyze various sources related to collagen-based hydrogel encapsulated cardiosphere-derived cell (CDC). This literature review is written systematically by gathering library sources from various search engines, such as Google Scholar, PubMed, and Research Gate. According to the findings of the study, CDC has the potential to be used as a post-AMI therapy because it can promote regeneration of the heart, which has lost function as a result of the AMI. To achieve the greatest effect, this modality is administered intracoronary. This modality will be encapsulated with collagen hydrogel, which has a cardioprotective effect, in order to increase the survival and effectiveness of CDC. The use of collagen-based hydrogel encapsulated CDC can provide post-AMI cell regeneration effects comparable to existing modalities while having minimal side effects. Further investigation in larger and more definitive trials is needed to elucidate the potential use of CDC therapy in AMI.
Co-Authors Prasetyo, Aizar Vesa Salim, Albert Suastika, Luh Olivia Saraswati Surya, Stevanus Christian Trapika, I Gusti Made Gde Surya Chandra